Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ACVR2B antibody (AA 45-150)

This anti-ACVR2B antibody is a Rabbit Polyclonal antibody detecting ACVR2B in WB, ELISA, ICC, IF (cc), IF (p), IHC (p) and IHC (fro). Suitable for Human and Rat.
Catalog No. ABIN1714650

Quick Overview for ACVR2B antibody (AA 45-150) (ABIN1714650)

Target

See all ACVR2B Antibodies
ACVR2B (Activin A Receptor, Type IIB (ACVR2B))

Reactivity

  • 77
  • 33
  • 32
  • 11
  • 9
  • 6
  • 6
  • 6
  • 6
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Human, Rat

Host

  • 75
  • 11
  • 3
  • 1
Rabbit

Clonality

  • 78
  • 12
Polyclonal

Conjugate

  • 43
  • 12
  • 4
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ACVR2B antibody is un-conjugated

Application

  • 78
  • 30
  • 22
  • 12
  • 12
  • 10
  • 8
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Binding Specificity

    • 14
    • 8
    • 7
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 45-150

    Cross-Reactivity

    Human, Rat

    Predicted Reactivity

    Mouse,Dog,Cow,Sheep,Pig

    Purification

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic peptide derived from human ACVR2B/ACTR-IIB

    Isotype

    IgG
  • Application Notes

    WB 1:300-5000
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    ICC 1:100-500

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    ACVR2B (Activin A Receptor, Type IIB (ACVR2B))

    Alternative Name

    ACVR2B/ACTR2B

    Background

    Synonyms: HTX4, ACTRIIB, ActR-IIB, Activin receptor type-2B, Activin receptor type IIB, ACVR2B

    Background: Transmembrane serine/threonine kinase activin type-2 receptor forming an activin receptor complex with activin type-1 serine/threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A/INHBA, activin-B/INHBB as well as inhibin-A/INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor.

    Gene ID

    93

    UniProt

    Q13705

    Pathways

    Hormone Transport, Cancer Immune Checkpoints
You are here:
Chat with us!